Table 1.
Descriptive statistics of patient characteristics at pre-treatment clinic visit
| Measure | Lovastatin | Placebo | P value |
|---|---|---|---|
| N, enrolled | 14 | 16 | |
| N, incomplete | 2 | 0 | |
| Age | 13.86 ± 2.14 | 13.17 ± 2.54 | 0.4307 |
| Sex | 0.2092 | ||
| Male | 12 | 16 | |
| Female | 2 | 0 | |
| Race/ethnicity | 0.05 | ||
| Caucasian | 14 | 10 | |
| Hispanic | 0 | 4 | |
| African American | 0 | 1 | |
| Asian | 0 | 1 | |
| Leiter-R Brief IQ standard score | 44.00 ± 9.22 | 43.13 ± 6.24 | 0.7604 |
| Leiter-R growth score | 461.40 ± 13.32 | 462.30 ± 8.57 | 0.8273 |
| ADOS-2 comparison score | 6.85 ± 2.54 | 6.75 ± 2.05 | 0.911 |
| Parent education level | 0.764 | ||
| HS grad/GED | 0 | 1 | |
| BA/BS | 5 | 6 | |
| Master’s degree + | 4 | 4 | |
| Some college | 2 | 5 | |
| Some grad work | 1 | 0 | |